BEVEXIA Trademark

Trademark Overview

On Tuesday, July 5, 2016, a trademark application was filed for BEVEXIA with the United States Patent and Trademark Office. The USPTO has given the BEVEXIA trademark a serial number of 87093603. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 24, 2020. This trademark is owned by Portola Pharmaceuticals, Inc.. The BEVEXIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation; pharmaceutical preparations for use as anticoagulants
bevexia

General Information

Serial Number87093603
Word MarkBEVEXIA
Filing DateTuesday, July 5, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 24, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation; pharmaceutical preparations for use as anticoagulants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 11, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePortola Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePortola Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, February 24, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 24, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2019EXTENSION 5 GRANTED
Thursday, July 11, 2019EXTENSION 5 FILED
Tuesday, July 16, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 11, 2019TEAS EXTENSION RECEIVED
Thursday, January 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 8, 2019EXTENSION 4 GRANTED
Tuesday, January 8, 2019EXTENSION 4 FILED
Tuesday, January 8, 2019TEAS EXTENSION RECEIVED
Friday, July 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 11, 2018EXTENSION 3 GRANTED
Wednesday, July 11, 2018EXTENSION 3 FILED
Wednesday, July 11, 2018TEAS EXTENSION RECEIVED
Thursday, January 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2018EXTENSION 2 GRANTED
Tuesday, January 9, 2018EXTENSION 2 FILED
Tuesday, January 9, 2018TEAS EXTENSION RECEIVED
Thursday, July 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 18, 2017EXTENSION 1 GRANTED
Tuesday, July 18, 2017EXTENSION 1 FILED
Tuesday, July 18, 2017TEAS EXTENSION RECEIVED
Tuesday, January 24, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 13, 2016ASSIGNED TO EXAMINER
Monday, July 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 8, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

bevexia pharmaceutical preparations cancers hematologic inflammation anticoagulants thrombosis coagulation oncology hematology